tiprankstipranks
Mainz Biomed regains compliance with Nasdaq Capital Market
PremiumThe FlyMainz Biomed regains compliance with Nasdaq Capital Market
27d ago
Mainz Biomed initiates U.S. study to evaluate CRC test
Premium
The Fly
Mainz Biomed initiates U.S. study to evaluate CRC test
1M ago
Mainz Biomed NV trading resumes
Premium
The Fly
Mainz Biomed NV trading resumes
1M ago
Mainz Biomed NV trading resumes
PremiumThe FlyMainz Biomed NV trading resumes
2M ago
Mainz Biomed NV trading halted, volatility trading pause
Premium
The Fly
Mainz Biomed NV trading halted, volatility trading pause
2M ago
Mainz Biomed Prices $8 Million Follow-On Offering to Boost Diagnostics Operations
Premium
Company Announcements
Mainz Biomed Prices $8 Million Follow-On Offering to Boost Diagnostics Operations
2M ago
Mainz Biomed announces 1-for-40 reverse stock split
PremiumThe FlyMainz Biomed announces 1-for-40 reverse stock split
3M ago
Mainz Biomed downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Mainz Biomed downgraded to Neutral from Buy at H.C. Wainwright
3M ago
Mainz Biomed Considers Reverse Stock Split for Nasdaq Compliance
Premium
Company Announcements
Mainz Biomed Considers Reverse Stock Split for Nasdaq Compliance
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100